Lloyd M. Kunimoto

Lloyd M. Kunimoto

Director Ejecutivo en Amfora, Inc. .

Health Technology
Consumer Services
Commercial Services

Perfil

Lloyd M.
Kunimoto
is currently the Director at Amfora, Inc. He previously held positions such as President & Chief Executive Officer at Calgene, Inc. from 1983 to 1997, President, Chief Executive Officer & Director at Galileo Pharmaceuticals, Inc. in 2008, Chief Executive Officer & Director at Epicyte Pharmaceutical, Inc., Senior Vice President-Corporate Development at Exelixis, Inc., Vice President-Corporate Strategy at Monsanto Co. from 2006 to 2010, and Senior Vice President-Corporate Development at Pacific Biosciences of California, Inc. He also served as the Chief Business Officer at Sapphire Energy, Inc. Mr. Kunimoto obtained his undergraduate degree from Stanford University.

Cargos activos de Lloyd M. Kunimoto

EmpresasCargoInicio
Director Ejecutivo -
Todos los cargos activos de Lloyd M. Kunimoto

Antiguos cargos conocidos de Lloyd M. Kunimoto.

EmpresasCargoFin
Corporate Officer/Principal 01/02/2014
MONSANTO Corporate Officer/Principal -
Presidente 16/12/2008
Calgene, Inc. Presidente 01/01/1997
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Corporate Officer/Principal -
Ver el detalle de la experiencia de Lloyd M. Kunimoto.

Formación de Lloyd M. Kunimoto.

Stanford University Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Lloyd M. Kunimoto.

Relaciones

43

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
EXELIXIS, INC.

Health Technology

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Health Technology

Empresas privadas6
Calgene, Inc.

Commercial Services

Distribution Services

Health Technology

Health Technology

Energy Minerals

Health Technology

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Lloyd M. Kunimoto
-40% Prolongación excepcional: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA